NGVT's shares rally as portfolio optimization, capacity investments and debt reduction boost confidence in long-term growth prospects.
Ingevity's Q2 2026 results show a potential inflection point with EPS of $1.00 versus a loss of $4.02 a year ago, driven by gross margin expansion to 44.3% and disciplined cost control. However, revenue contracted 14% year-over-year, marking the tenth consecut...
Price trend, volume and key moving averages
Trailing total returns as of 10/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 29, 2026 | $1.74+30.8% vs $1.33 | $314M+0.6% vs $312M |
Q2 2026 May 6, 2026 | $1.15+36.9% vs $0.84 | $258M+1.3% vs $255M |
Q1 2026 Feb 25, 2026 | $0.58-12.8% vs $0.67 | $255M-0.8% vs $257M |
Q4 2025 Nov 5, 2025 | $1.31+92.6% vs $0.68 | $333M+29.5% vs $257M |
NGVT's shares rally as portfolio optimization, capacity investments and debt reduction boost confidence in long-term growth prospects.
Ingevity NYSE: NGVT is nearing completion of a strategic portfolio transformation that has narrowed its focus to its Performance Materials and Pavement Technologies businesses, President and Chief Executive Officer David Li said during a Water Tower Research conference session.
Valuation Assessment of Ingevity Corp (NGVT)On September 22, 2026, Ingevity Corp (NGVT) shares rose 3.4% to a current price of $71.27. The stock has experienced

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity will participate in a fireside chat at the 2026 Water Tower Research Insights Conference.
Benchmark NGVT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Ingevity Corporation (NGVT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $71.09 | $2.47B | -15.42 | -16.98% | -14.31% | -148.6% | — | |
| $50.23 | $2.7B | 18.27 | -2.67% | 5.56% | 9.51% | — | |
| $95.17 | $2.34B | 20.38 | -3.65% | 6.6% | 9.1% | — | |
| $158.39 | $2.75B | -1131.36 | 2.66% | 4.94% | 7.1% | — | |
| $76.35 | $3.94B | 12.68 | -7.04% | 5.23% | 11.09% | — | |
| $15.98 | $430.81M | 8.88 | 0.31% | -1.14% | -2.2% | — |
Ingevity Corporation (NGVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Ingevity Corporation (NGVT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 29, 2026·SEC
Jun 24, 2026·SEC
May 6, 2026·SEC
Get notified when NGVT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ingevity Corporation (NGVT) stock FAQ — growth, dividends, profitability & financials explained
Ingevity Corporation (NGVT) reported $1.16B in revenue for fiscal year 2025. This represents a 18% increase from $980.0M in 2013.
Ingevity Corporation (NGVT) saw revenue decline by 17.0% over the past year.
Yes, Ingevity Corporation (NGVT) is profitable, generating $54.0M in net income for fiscal year 2025 (-14.3% net margin).
Ingevity Corporation (NGVT) has a return on equity (ROE) of -148.6%. Negative ROE indicates the company is unprofitable.
Ingevity Corporation (NGVT) generated $154.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.